Clinical Trial Update: Persantine: Variation in Response Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Persantine (dipyridamole) investigating variation in response in coronary artery disease; the study was terminated and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Persantine (Dipyridamole)

Snippet

Sponsor: UConn Health | Conditions: Coronary Artery Disease | Phase 4 | Status: TERMINATED | Results posted: 2017-05-24